Burning Rock Biotech Q2 EPS $(0.20) Down From $(0.10) YoY, Sales $19.862M Down From $20.737M YoY
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.20) per share. This is a 100 percent decrease over losses of $(0.10) per share from the same period last year. The company reported $19.862 million in
Burning Rock Biotech lost more money per share this quarter than last year, and sales dropped a little bit too. When a company is losing more money and selling less, watch to see if they can turn things around soon.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.